APA (7th ed.) Citation

Schnülle, P., Kölling, S., Müller, A., & Schmitt, W. (2022). Short-time interruption of second-line mycophenolate treatment in a patient with renal sarcoidosis enabled a marked antibody response to SARS-CoV-2 messenger RNA vaccine: Letter to the editor. Clinical kidney journal, 15(3), . https://doi.org/10.1093/ckj/sfab289

Chicago Style (17th ed.) Citation

Schnülle, Peter, Sebastian Kölling, Alexander Müller, and Wilhelm Schmitt. "Short-time Interruption of Second-line Mycophenolate Treatment in a Patient with Renal Sarcoidosis Enabled a Marked Antibody Response to SARS-CoV-2 Messenger RNA Vaccine: Letter to the Editor." Clinical Kidney Journal 15, no. 3 (2022). https://doi.org/10.1093/ckj/sfab289.

MLA (9th ed.) Citation

Schnülle, Peter, et al. "Short-time Interruption of Second-line Mycophenolate Treatment in a Patient with Renal Sarcoidosis Enabled a Marked Antibody Response to SARS-CoV-2 Messenger RNA Vaccine: Letter to the Editor." Clinical Kidney Journal, vol. 15, no. 3, 2022, https://doi.org/10.1093/ckj/sfab289.